Dr. Justin Hughey has been appointed to lead Particle Design sciences at Hovione’s site in NJ. Dr. Hughey is an expert in the field of solubilization including the creation of amorphous solid dispersions with emphasis on Hot Melt Extrusion. Additionally, Hovione is investing in both lab and mid-scale Hot Melt Extruders to help enable the efficient development of particles with improved solubility, scale up, and transfer to clinical manufacture. 

Dr. Hughey most recently served as director of research for Austin-based Enavail. He has authored more than 30 publications, posters and book chapters. His pharmaceutical development experience extends to particle engineering technologies for pulmonary delivery as well as controlled and immediate release solid oral dosage forms.  

“I am delighted to announce the appointment of Dr. Hughey. With his experience and deep scientific knowledge in developing traditional and non-traditional dosage forms with a strong emphasis on Hot Melt Extrusion and other novel processing techniques, I believe he will help speedily solve bioavailability challenges brought to us by our customers,” said Dr. Colin Minchom, vice president Particle Design.